Compounds > ag 127

ag 127 and ag-213

ag 127 has been researched along with ag-213 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gazit, A; Gilon, C; Levitzki, A; Yaish, P	1
Bachelot, C; Eldor, A; Gazit, A; Gilon, C; Grelac, F; Levitzki, A; Levy-Toledano, S; Rendu, F	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J	1

Other Studies

4 other study(ies) available for ag 127 and ag-213

Article	Year
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. Journal of medicinal chemistry, 1989, Volume: 32, Issue:10 Topics: Benzylidene Compounds; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Structure; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Structure-Activity Relationship	1989
Inhibition of platelet activation by tyrosine kinase inhibitors. Biochemical pharmacology, 1992, Sep-01, Volume: 44, Issue:5 Topics: Catechols; Humans; Nitriles; Nitrophenols; Phosphatidylinositols; Phosphorylation; Phosphotyrosine; Platelet Activation; Platelet Aggregation Inhibitors; Protein-Tyrosine Kinases; Thrombin; Tyrosine; Tyrphostins	1992
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology, 2009, Volume: 5, Issue:10 Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection	2009